Are the criteria for reporting adverse events unnecessarily derailing some clinical trials? We’ll find out with Robert Jeanfreau, MD, CPI, owner/medical director at MedPharmics, LLC.
Riddled with ethical and legal landmines, informed consent remains one of the most important and challenging aspects of clinical trials. In this Clinical Trial Insights podcast, we hear from a number of experts who examine informed consent from a variety of vantage points. You’ll gain valuable perspectives on how the new International Council on Harmonization […]
For more than a decade, technologists and other experts have said we’re just around the corner when it comes to the virtually paperless clinical trial. How’s that been working out for you? In this podcast, you’ll hear from four experts who offer perspectives on why the paperless wave has been slow to spread and what […]